Glutathione for skin lightning: A regnant myth or evidence-based verity

Glutathione for skin lightning: A regnant myth or evidence-based verity

Authors

  • Sidharth Sonthalia SKINNOCENCE: The Skin Clinic & Research Centre, Gurugram, India
  • Abhijeet Kumar Jha Department of Skin & VD, Patna Medical College, Patna, India
  • Aimilios Lallas First Department of Dermatology, Aristotle University, Thessaloniki, Greece
  • Geraldine Jain Punarnawah Medical & Research Centre, Jaipur, India
  • Deepak Jhakar Consultant Dermatologist & Cosmetologist, New Delhi, India

Keywords:

glutathione, skin lightning, intravenous, GSH, GSSG

Abstract

The recent hype surrounding the antimelanogenic properties of glutathione has resulted in physicians frequently administering it as a “wonder” drug for skin lightening and treatment of hyperpigmentation, especially in ethnic populations with darker skin tones. This phenomenon has seen a recent surge owing to aggressive marketing and capitalization of pharma-cosmeceutical companies. However, the unbridled and prodigal use of it, especially as a parenteral formulation, seems unjustified, given the lacunae in our knowledge about its antimelanogenic potential, limited clinical evidence favoring its role in skin lightening, and the statutory ban/advisory issued by certain federal agencies. Even though parenteral glutathione is approved only for severe liver disorders and for prevention of chemotherapy associated neurotoxicity, the lack of statutory laws governing the use of systemic glutathione in most countries has contributed to its unchecked use for skin lightening. The current clinical evidence of intravenous glutathione for skin lightening is limited to a single study with a dubious study design and apparently flawed analysis of results, casting doubt on the drug's efficacy and reported adverse effects. Two studies evaluating oral/sublingual administration and one trial involving the use of topical glutathione reported good safety profile and appreciable but reversible results on skin tone. In this article, we shall review and discuss the current status of glutathione as a skin lightening agent and address the sundry unanswered queries regarding the dosage, duration of use and longevity of accrued effects based on clinical evidence and recent insights into its antimelanogenic mechanism.

References

Sarkar R, Chugh S, Garg VK. Newer and upcoming therapies for melasma. Indian J Dermatol Venereol Leprol. 2012;78:417-28.

Villarama CD, Maibach HI. Glutathione as a depigmenting agent: An overview. Int J Cosmet Sci. 2005;27:147-53.

Sonthalia S, Daulatabad D, Sarkar R. Glutathione as a skin whitening agent: Facts, myths, evidence and controversies. Indian J Dermatol Venereol Leprol. 2016;82:262-72.

Arjinpathana N, Asawanonda P. Glutathione as an oral whitening agent: a randomized, double-blind, placebo-controlled study. J Dermatolog Treat 2012;23:97-102.

Handog EB, Datuin MS, Singzon IA. An open-label, single-arm trial of the safety and efficacy of a novel preparation of glutathione as a skin-lightening agent in Filipino women. Int J Dermatol 2016;55:153-7.

Watanabe F, Hashizume E, Chan GP, Kamimura A. Skin-whitening and skin-condition-improving effects of topical oxidized glutathione: a double-blind and placebo-controlled clinical trial in healthy women. Clin Cosmet Investig Dermatol 2014;7:267-74.

Zubair S, Hafeez S, Mujtaba G. Efficacy of intravenous glutathione vs. placebo for skin tone lightening. J Pak Ass Dermatol. 2016;26:177-81.

Taylor SC, Arsonnaud S, Czernielewski J; Hyperpigmentation Scale Study Group. The Taylor Hyperpigmentation Scale: a new visual assessment tool for the evaluation of skin color and pigmentation. Cutis. 2005;76:270-4.

Lazo SH. Safety on the off-label use of glutathione solution for injection (IV). Food and Drug Adminitration, Department of Health, Republic of the Phillipines; 2011. URL http://www.doh.gov.ph/sites/default/files/Advisories_cosmetic_DOH-FDA%20Advisory%20No.%202011-004.pdf. [accessed on 26th February 2017].

GRAS notice for Glutathione. (2009) URL http://www.fda.gov/ucm/groups/fdagov-public/@fdagov-foods-gen/documents/document/ucm269318.pdf [accessed on 26 April 2017].

Lenzi A, Lombardo F, Gandini L, Culasso F, Dondero F. Glutathione therapy for male infertility. Arch Androl. 1992;29:65-8.

Cook GC, Sherlock S. Results of a controlled clinical trial of glutathione in cases of hepatic cirrhosis. Gut. 1965;6:472-6.

Potterf SB, Virador V, Wakamatsu K, Furumura M, Santis C, Ito S, et al. Cysteine transport in melanosomes from murine melanocytes. Pigment Cell Res 1999;12:4–12.

Wellner VP, Anderson ME, Puri RN, Jensen GL, Meister A. Radioprotection by glutathione ester: Transport of glutathione ester into human lymphoid cells and fibroblasts. Proc Natl Acad Sci USA 1984;81:4732–5.

Chung BY, Choi SR, Moon IJ, Park CW, Kim YH, Chang SE. The Glutathione Derivative, GSH Monoethyl Ester, May Effectively Whiten Skin but GSH Does Not. Int J Mol Sci 2016;27;17:629 doi:10.3390/ijms17050629.

http://www.cdsco.nic.in/writereaddata/Notice%20DTAB.pdf [accessed on 26th April 2017].

http://www.cdsco.nic.in/writereaddata/LISTOF-APPROVED-DRUG-FROM-2011.pdf. [accessed on 26th April 2017].

Downloads

Published

2018-01-31

Issue

Section

Review

How to Cite

1.
Glutathione for skin lightning: A regnant myth or evidence-based verity. Dermatol Pract Concept [Internet]. 2018 Jan. 31 [cited 2024 May 19];8(1). Available from: https://dpcj.org/index.php/dpc/article/view/dermatol-pract-concept-articleid-dp0801a04

Share